IDEAS home Printed from https://ideas.repec.org/p/fda/fdaddt/2024-04.html
   My bibliography  Save this paper

The Welfare Effects of Degrowth as a Decarbonization Strategy

Author

Listed:
  • Javier Andrés
  • José Emilio Boscá
  • Rafael Doménech
  • Javier Ferri

Abstract

We evaluate the welfare and macroeconomic implications of three distinct strategies aimed at reducing carbon emissions, which could be categorized within the diverse landscape of ideas encompassed by the degrowth literature. These strategies include penalizing fossil fuel demand, substituting aggregate consumption with leisure, and curbing consumption by limiting total factor productivity growth. Using an environmental dynamic general equilibrium model (eDGE) that incorporates both green renewable technologies and fossil fuels in the production process, our study sets an emissions reduction target aligned with the goals of the Paris Agreement by 2050. The results reveal that the strategies analyzed, which most closely align with the strictest interpretations of degrowth—namely, a reduction in the consumption of goods and services compensated by an increase in leisure, or strong impediments against conventional economic growth—may entail significant economic consequences, leading to a notable decline in welfare. In particular, a degrowth scenario aimed at curbing consumption through a decline in Total Factor Productivity (TFP) yields the most pronounced reduction in welfare. Conversely, inducing a reduction in fossil fuel demand by increasing the price of fossil fuels through taxes, despite potential social backlash, shows noticeably less detrimental effects on welfare compared to other degrowth policies. Furthermore, under this degrowth strategy, our findings suggest that a globally coordinated strategy could result in long-term welfare gain.

Suggested Citation

  • Javier Andrés & José Emilio Boscá & Rafael Doménech & Javier Ferri, 2024. "The Welfare Effects of Degrowth as a Decarbonization Strategy," Working Papers 2024-04, FEDEA.
  • Handle: RePEc:fda:fdaddt:2024-04
    as

    Download full text from publisher

    File URL: https://documentos.fedea.net/pubs/dt/2024/dt2024-04.pdf
    Download Restriction: no
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:fda:fdaddt:2024-04. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Carmen Arias (email available below). General contact details of provider: https://www.fedea.net .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.